EPISARS

Prevention of future SARS epidemics through the control of animal and human infection



 

Link to

Pubmed Central


 

Publications

2004 2005 2006 2007

Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, Zhang H, Luo H, Zhu L, Jiang P, Chen L, Shen Y, Luo M, Zuo G, Hu J, Duan D, Nie Y, Shi X, Wang W, Han Y, Li T, Liu Y, Ding M, Deng H, Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol. 2004;78:11334-9. Abstract.

Nie Y, Wang P, Shi X, Wang G, Chen J, Zheng A, Wang W, Wang Z, Qu X, Luo M, Tan L, Song X, Yin X, Chen J, Ding M, Deng H. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem Biophys Res Commun. 2004;321:994-1000. Abstract.

Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, Wang W, Lian G, Yin X, Du L, Ren L, Wang J, He X, Li T, Deng H, Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis. 2004;190:1119-26. Epub 2004 Aug 2. Abstract.

Liu W, Tang F, Fontanet A, Zhan L, Zhao QM, Zhang PH, Wu XM, Zuo SQ, Baril L, Vabret A, Xin ZT, Shao YM, Yang H, Cao WC. Long-term SARS coronavirus excretion from patient cohort, China. Emerg Infect Dis. 2004;10:1841-3. Abstract.

Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol. 2004 Jul;78(13):6938-45. Abstract.

 


For any questions or suggestions, please contact the webmaster : Marie-Hélène Chang